Greg Kidd to acquire a controlling stake in Know Labs and debut Bitcoin Treasury Strategy Greg Kidd will acquire a controlling stake through the use of Bitcoin and cash, becoming CEO and Chairman of Know Labs. Know Labs will adopt a Bitcoin fiscal strategy, with Bitcoin accounting for 82% of its market capitalization. Founder Ron Erickson will lead a new division focused on non-invasive diagnostic research in response to the transition of leadership. Know Labs, a U.S.-based, NYSE American listed health technology company, is preparing for a major leadership and strategic transformation. The company has entered into an agreement with Goldeneye 1995 LLC, an affiliate of fintech investor Greg Kidd, to acquire a controlling stake. Upon closing, Kidd will serve as Chief Executive Officer and Chairman of the Board of Directors. Bitcoin-Funded Acquisition with Fiscal Rebalancing The transaction involves a buyer acquiring common stock by dividing the sum of 1,000 bitcoins with additional cash by a price of $0.335 per share. The cash will be used to repay current debt, redeem outstanding preferred equity, and provide new working capital. The Bitcoin portion of the acquisition will become the core of Know Labs' treasury reserves. The company will adopt a Bitcoin fiscal strategy after the acquisition. As part of this transition, Know Labs will employ a net asset value multiple (mNAV) to measure the company's valuation relative to its Bitcoin holdings. Based on a price of $105,000 per bitcoin and a market cap of $128 million, Bitcoin holdings would account for 82% of the total valuation. The implied entry multiple is equal to 1.22 times the net asset value. Ron Erickson, current founder and CEO of Leadership Change & Continuing Research, will transition to the role of President of the newly formed division. He will also serve as Vice Chairman of the Board of Directors. The department will retain a dedicated research team to continue working on non-invasive diagnostic techniques. Know Labs has historically focused on health monitoring systems using proprietary sensor platforms. The Board unanimously approved the transaction. Shareholder approvals and regulatory conditions must be met before the agreement can be completed and is expected to be completed in the third quarter of 2025. Strategic Rationale and Advisory Role: Greg Kidd, formerly Ripple's Chief Risk Officer, will bring his team and existing digital asset strategy to the public markets through Know Labs. According to the agreement, Bitcoin's treasury structure will support a shift in the company's approach to capital allocation. The deal marks Kidd's latest move in the blockchain and fintech space. His team will contribute their existing Bitcoin yield generation strategy under the Know Labs umbrella. The buyer received legal counsel from Lowenstein Sandler LLP and Cohen & Company Capital Markets acted as financial advisor. During the negotiation process, Know Labs retained Sichenzia Ross Ference Carmel LLP as legal counsel.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Greg Kidd to acquire a controlling stake in Know Labs and debut Bitcoin Treasury Strategy Greg Kidd will acquire a controlling stake through the use of Bitcoin and cash, becoming CEO and Chairman of Know Labs. Know Labs will adopt a Bitcoin fiscal strategy, with Bitcoin accounting for 82% of its market capitalization. Founder Ron Erickson will lead a new division focused on non-invasive diagnostic research in response to the transition of leadership. Know Labs, a U.S.-based, NYSE American listed health technology company, is preparing for a major leadership and strategic transformation. The company has entered into an agreement with Goldeneye 1995 LLC, an affiliate of fintech investor Greg Kidd, to acquire a controlling stake. Upon closing, Kidd will serve as Chief Executive Officer and Chairman of the Board of Directors. Bitcoin-Funded Acquisition with Fiscal Rebalancing The transaction involves a buyer acquiring common stock by dividing the sum of 1,000 bitcoins with additional cash by a price of $0.335 per share. The cash will be used to repay current debt, redeem outstanding preferred equity, and provide new working capital. The Bitcoin portion of the acquisition will become the core of Know Labs' treasury reserves. The company will adopt a Bitcoin fiscal strategy after the acquisition. As part of this transition, Know Labs will employ a net asset value multiple (mNAV) to measure the company's valuation relative to its Bitcoin holdings. Based on a price of $105,000 per bitcoin and a market cap of $128 million, Bitcoin holdings would account for 82% of the total valuation. The implied entry multiple is equal to 1.22 times the net asset value. Ron Erickson, current founder and CEO of Leadership Change & Continuing Research, will transition to the role of President of the newly formed division. He will also serve as Vice Chairman of the Board of Directors. The department will retain a dedicated research team to continue working on non-invasive diagnostic techniques. Know Labs has historically focused on health monitoring systems using proprietary sensor platforms. The Board unanimously approved the transaction. Shareholder approvals and regulatory conditions must be met before the agreement can be completed and is expected to be completed in the third quarter of 2025. Strategic Rationale and Advisory Role: Greg Kidd, formerly Ripple's Chief Risk Officer, will bring his team and existing digital asset strategy to the public markets through Know Labs. According to the agreement, Bitcoin's treasury structure will support a shift in the company's approach to capital allocation. The deal marks Kidd's latest move in the blockchain and fintech space. His team will contribute their existing Bitcoin yield generation strategy under the Know Labs umbrella. The buyer received legal counsel from Lowenstein Sandler LLP and Cohen & Company Capital Markets acted as financial advisor. During the negotiation process, Know Labs retained Sichenzia Ross Ference Carmel LLP as legal counsel.